TickerFacts.

Aurinia Pharmaceuticals Inc. (AUPH): Share Repurchases

Annual figures by period end, from SEC filings.

$98.16M
Year ended 2025-12-31
$83.55M
Trailing 12 months to 2026-06-30
2022-12-31: $02023-12-31: $02024-12-31: $40.24M2025-12-31: $98.16M$98.16M
2022-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$98.16M+143.9%2026-02-26, From 2025-01-01
2024-12-31$40.24Mn/a2026-02-26, From 2024-01-01
2023-12-31$0n/a2026-02-26, From 2023-01-01
2022-12-31$0n/a2025-02-27, From 2022-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Aurinia Pharmaceuticals Inc. (AUPH)2025-12-31$98.16M+143.9%
Cryoport, Inc. (CYRX)2025-12-31$10.01Mn/a
Vera Therapeutics, Inc. (VERA)2025-12-31$0-100.0%
Arvinas, Inc. (ARVN)2025-12-31$91.90Mn/a
Corcept Therapeutics Inc (CORT)2025-12-31$172.91Mn/m
BridgeBio Pharma, Inc. (BBIO)2025-12-31$48.28Mn/a
Organogenesis Holdings Inc. (ORGO)2024-12-31$25.48Mn/a
Standard Biotools Inc. (LAB)2025-12-31$0-100.0%
Theravance Biopharma, Inc. (TBPH)2024-12-31$445.0K-99.8%

Compare AUPH, CYRX, VERA, ARVN side by side · Screen every company in Pharmaceutical Preparations ↗